Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial.

Baber U, Cao D, Collier T, Sartori S, Dangas G, Angiolillo DJ, Vogel B, Kunadian V, Briguori C, Cohen DJ, Dudek D, Gibson CM, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R

Open source

DOI: 10.1093/ehjcvp/pvae080
Published: 2025 Feb 8
Container: European heart journal. Cardiovascular pharmacotherapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvae080,
  title = {Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial.},
  author = {Baber U and Cao D and Collier T and Sartori S and Dangas G and Angiolillo DJ and Vogel B and Kunadian V and Briguori C and Cohen DJ and Dudek D and Gibson CM and Gil R and Huber K and Kaul U and Kornowski R and Krucoff MW and Mehta S and Moliterno DJ and Ohman EM and Escaned J and Sardella G and Sharma SK and Shlofmitz R and Weisz G and Witzenbichler B and Steg PG and Pocock S and Mehran R},
  year = {2025},
  journal = {European heart journal. Cardiovascular pharmacotherapy},
  doi = {10.1093/ehjcvp/pvae080},
  url = {https://doi.org/10.1093/ehjcvp/pvae080}
}

RIS

TY  - JOUR
TI  - Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial.
AU  - Baber U
AU  - Cao D
AU  - Collier T
AU  - Sartori S
AU  - Dangas G
AU  - Angiolillo DJ
AU  - Vogel B
AU  - Kunadian V
AU  - Briguori C
AU  - Cohen DJ
AU  - Dudek D
AU  - Gibson CM
AU  - Gil R
AU  - Huber K
AU  - Kaul U
AU  - Kornowski R
AU  - Krucoff MW
AU  - Mehta S
AU  - Moliterno DJ
AU  - Ohman EM
AU  - Escaned J
AU  - Sardella G
AU  - Sharma SK
AU  - Shlofmitz R
AU  - Weisz G
AU  - Witzenbichler B
AU  - Steg PG
AU  - Pocock S
AU  - Mehran R
PY  - 2025
JO  - European heart journal. Cardiovascular pharmacotherapy
DO  - 10.1093/ehjcvp/pvae080
UR  - https://doi.org/10.1093/ehjcvp/pvae080
ER  -

APA

U, B., D, C., T, C., S, S., G, D., DJ, A., B, V., V, K., C, B., DJ, C., D, D., CM, G., R, G., K, H., U, K., R, K., MW, K., S, M., DJ, M., EM, O., J, E., G, S., SK, S., R, S., G, W., B, W., PG, S., S, P., & R, M. (2025). Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial.. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae080

Source records

pubmed · retrieved 2026-09-27T11:21:09.050Z